Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Country / region: South Korea Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20072
20082
20091
20102
20112
20122
20131
20151
20181
20201
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status6
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Hallym University Medical Center2
Seoul National University Childrens Hospital2
Seoul National University Hospital2
Yuyu Pharma, Inc.2
Alvogen Korea1
Asan Medical Center1
Biomix1
Bundang CHA Hospital1
Daegu Catholic University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity22
Mental Disorders4
Autism Spectrum Disorder1
Brain Injuries, Traumatic1
Cognitive Dysfunction1
Developmental Disabilities1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.